Rosai-Dorfman Disease Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 October 04
SKU : PH6811
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
FAQ’s
What is the Projected CAGR value of the Rosai-Dorfman Disease Market ?
Rosai-Dorfman Disease Market is expected to grow at a CAGR of 6.6% during the forecast period 2023-2030.
Who are the key players in Rosai-Dorfman Disease Market ?
Major players are GE HealthCare, Canon Inc, Siemens Healthineers, SternMed GmbH, Jubilant Cadista Pharmaceuticals Inc, LGM Pharma, Henan Lihua Pharmaceutical Co Ltd, Niksan Pharmaceutical, and Sandoz Canada Inc.